26 results on '"Feng, W."'
Search Results
2. Urine- and Plasma-Based Detection of Minimal Residual Disease in Localized Bladder Cancer Patients
3. Urinary Tumor DNA Detection of Muscle-Invasive Bladder Cancer May be Superior to Surgical Pathologic Complete Response Status for Predicting Survival Outcomes
4. Postoperative Radiation Therapy for Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer: A Population Study from 1988 to 2014 Using the Surveillance, Epidemiology, and End Results Database
5. Late Toxicities Differed Maximum Tolerated Dose Determined by Acute Toxicities: Reanalysis of a Phase I/II Trial of Dose Escalation in Unresectable Thoracic Esophageal Cancer by Simultaneous Integrated Boost
6. Neoadjuvant Chemoradiation is Associated With Improved Overall Survival in Elderly Patients With Esophageal Cancer
7. A CRISPR Screen to Systematically Identify DNA Repair Gene Alterations that Modulate Sensitivity to DNA Damaging Agents
8. Feasibility and Safety of the Clinical Target Volume Design for Postoperative Radiation Therapy in Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer: A Prospective Validation Study
9. The Differential Impact of Postoperative Radiation Therapy for Completely Resected Stage IIIA (N2) Non-Small Cell Lung Cancer: Based on the Risk Prediction Model for Locoregional Recurrence
10. Mre11 Dysfunction Is Associated With Triple-Negative Breast Cancer and Confers Sensitivity to DNA Damaging Therapy
11. A Randomized Phase 2 Trial Estimating the Optimal Radiation Volume of Postoperative Radiation Therapy for Patients With Locoregionally Advanced Thoracic Esophageal Squamous Cell Carcinoma—A Preliminary Report (NCT01391572)
12. Failure Modes and Effects Analysis (FMEA): Based Quality Management Program for Stereotactic Radiosurgery
13. Risk Factors of Brain Metastases as Initial Failure for Completely Resected Stage IIIA (N2) Non-Small Cell Lung Cancer
14. The Emerging Outcome of Postoperative Radiation Therapy for Stage IIIA(N2) Non-Small Cell Lung Cancer: Based on 3D Conformal Techniques and Institutional Standard Clinical Target Volume
15. The Effect of Energy Index on Brain Metastases Local Control With Stereotactic Radiosurgery
16. Safety of Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer
17. Stromal Contributions to Radiation Resistance of Breast Cancer Stem Cells
18. Patterns of Local-Regional Failure in Completely Resected Stage IIIa (N2) Non-Small Cell Lung Cancer Patients: Implications for Postoperative Radiation Therapy Target Volumes
19. Selective Internal Radiation Therapy to the Liver: High Tumor Dose and Normal Liver Tolerance
20. Prognostic Index for Estimating the Effect of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer: A Real-World Validation Study.
21. Comparing Lung Dosimetry and Secondary Malignancy Risks Associated With Stereotactic Body Radiation Therapy (SBRT) Using Intensity Modulated Radiation Therapy (IMRT), Coplanar Volumetric Modulated Arc Therapy (VMAT), and Noncoplanar Volumetric Modulated Arc Therapy Techniques
22. Study on the Rationale of Postoperative Radiation Therapy Target Volumes in Completely Resected Stage IIIa (N2) Non-small Cell Lung Cancer
23. Elimination of Phase Delay of External Surrogate-based Respiratory Gating System to Reduce PTV Margins using a Novel Ultrasound-based Apparatus
24. Improve Accuracy in the Delineation of the Trigeminal Nerve using T1-weighted and FIESTA MRI Sequences for Trigeminal Neuralgia Radiosurgery
25. Can Ultra-low-pass Whole Genome Sequencing from Blood Plasma Detect Transformation to Malignant Peripheral Nerve Sheath Tumor in Patients with Neurofibromatosis Type I?
26. Size-based Enrichment Of Urinary Cell-free DNA Compared To Plasma Cell-free DNA For Liquid Biopsy Analysis Of Oligometastatic Colorectal Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.